首页 | 本学科首页   官方微博 | 高级检索  
     


Evaluation of outcomes with apixaban use for venous thromboembolism in hospitalized patients with end-stage renal disease receiving renal replacement therapy
Authors:Chen  Jingshi  Nguyen  Steffany  Ruegger  Melanie  Samuel  Leena  Salazar  Eric  Dunne  Ian
Affiliation:1.Department of Pharmacy, Houston Methodist Hospital, 6565 Fannin Street, Houston, TX, DB1-09, USA
;2.Department of Medicine, Houston Methodist Hospital Institute for Academic Medicine, Houston, TX, USA
;3.Department of Pathology and Genomic Medicine, Houston Methodist Hospital, Houston, TX, USA
;4.Weill Cornell Medical College, Houston, TX, USA
;
Abstract:Journal of Thrombosis and Thrombolysis - While direct oral anticoagulants (DOACs) received expanded labeling for use in atrial fibrillation (AF) for end-stage renal disease (ESRD) based on...
Keywords:
本文献已被 SpringerLink 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号